Christopher Haqq
Overview
Christopher Haqq received an average of $2M in total compensation, including $360K in salary, at Atara Biotherapeutics from 2013 to 2016.
Source: SEC filings on April 24, 2017, April 29, 2016, and April 28, 2015.
Related executives
We found ten more executives who work or worked at Atara Biotherapeutics.
Isaac Ciechanover
Atara Biotherapeutics
Chief Executive Officer
Pascal Touchon
Atara Biotherapeutics
Chief Executive Officer
Dietmar Berger
Atara Biotherapeutics
Former Global Head of Research & Development
Joseph Newell
Atara Biotherapeutics
EVP, Chief Technical Operations Officer
Utpal Koppikar
Atara Biotherapeutics
Chief Financial Officer
Mina Kim
Atara Biotherapeutics
General Counsel
Derrell Porter
Atara Biotherapeutics
SVP and Global Commercial Head
Gad Soffer
Atara Biotherapeutics